CTRI/2018/01/011097已完成未知
Study of Postoperative Pain Relief After Caesarean Delivery Under Subarachnoid Block
ADY HARDINGE MEDICAL COLLEGE0 个研究点目标入组 457 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 457
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Healthy parturients (ASA physical status I and II) scheduled to undergo lower segment Caesarean section under subarachnoid block.
排除标准
- •ASA III and IV (Myocardial {NYHA class IIIâ??IV}, severe cerebrovascular, renal or hepatic impairment), refuse subarachnoid block, any contraindication to subarachnoid block (infection at the needle insertion site, spinal deformity, coagulation disorders) or to nerve block or to intramuscular injections, body weight >90Kg or <40Kg, history of relevant drug allergy or chronic pain, inability to understand study protocol or unable to communicate, patients receiving a combination of analgesic techniques, patients in whom subarachnoid block is inadequate for conduct of surgery.
研究者
相似试验
尚未招募
不适用
on sedative pain relief in women after Caesarean section by electrical stimulation of pressure points on the skin surface behind the earsCTRI/2022/04/041633Dr V Mangal Swathi
尚未招募
不适用
Study for postoperative pain control of continuous trans-catheter local anestheticcardiac valve diseadeJPRN-UMIN000025488St. marianna University school of Medicine100
进行中（未招募）
不适用
Postoperative pain after cesarean section :efficacy of S-ketamine at antihyperalgesic doses. - NDPostoperative pain after cesarean sectionMedDRA version: 6.1Level: PTClassification code 10006924EUCTR2006-005635-25-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
已完成
不适用
Post-caesarean section analgesia: efficacy of in-wound infusion for levobupivacaine and ketorolacAnalgesia after c-sectionO82Single delivery by caesarean sectionDRKS00006559KC Maribor61
尚未招募
Unknown
Post Caesarean Section Analgesia: A Comparative Study of Double Versus Triple Drug Combinations for Post Caesarean Section Analgesia at the Federal Medical Centre, Abuja- A Triple Blind Randomized Controlled Study.PACTR202404650060916234